3. New Advanced Prostate Cancer Treatment Approach, Combining Radiotherapies, Being Tested in Belfast
Queen’s University Belfast researchers, in partnership with the Belfast Trust, are leading a clinical trial evaluating a new combination of two radiotherapy treatments in men with advanced prostate cancer (PC), where the cancer has spread to the bones.
The ADRRAD trial, for Androgen Deprivation Therapy, Pelvic Radiotherapy and Radium-223 for presentation T1-4 N/1 M1B adenocarcinoma of prostate, has already started at the Northern Ireland Cancer Centre, Belfast, and is funded by Friends of the Cancer Centre and Bayer Pharmaceuticals.